Note Agreements in the Pharmaceuticals Industry
1,602 Contracts & Agreements
- 4Front Ventures Corp. (2 contracts)
- 60 DEGREES PHARMACEUTICALS, INC. (29)
- Acacia Diversified Holdings, Inc. (1)
- Acasti Pharma Inc. (8)
- Accelerated Pharma, Inc. (8)
- Acer Therapeutics Inc. (12)
- ACHILLION PHARMACEUTICALS INC (7)
- Acreage Holdings, Inc. (1)
- ACURA PHARMACEUTICALS, INC (20)
- Adamis Pharmaceuticals Corp (17)
- ADIAL PHARMACEUTICALS, INC. (9)
- Aegerion Pharmaceuticals, Inc. (8)
- AEOLUS PHARMACEUTICALS, INC. (5)
- AEON Biopharma, Inc. (8)
- AERIE PHARMACEUTICALS INC (2)
- Aerpio Pharmaceuticals, Inc. (4)
- AGILE THERAPEUTICS INC (1)
- Akers Biosciences, Inc. (3)
- AKESIS PHARMACEUTICALS, INC. (1)
- Akorn (6)
- Alexza Pharmaceuticals Inc. (8)
- ALIMERA SCIENCES INC (1)
- Allergan, plc (1)
- ALSERES PHARMACEUTICALS INC (28)
- Altus Pharmaceuticals Inc. (4)
- Amag Pharmaceuticals (2)
- AmeriCann, Inc. (5)
- Amphastar Pharma (1)
- Ampio Pharmaceuticals, Inc. (6)
- AMYLIN PHARMACEUTICALS INC (6)
- Angion Biomedica Corp. (3)
- ANGIOTECH PHARMACEUTICALS INC (4)
- ANI Pharma Inc (1)
- Applied BioSciences Corp. (5)
- APRICUS BIOSCIENCES, INC. (13)
- Aquestive Therapeutics, Inc. (2)
- ARADIGM CORP (6)
- Aralez Pharmaceuticals Inc. (15)
- ARIAD PHARMACEUTICALS INC (5)
- ARTELO BIOSCIENCES, INC. (2)
- Artemis Therapeutics, Inc. (3)
- Assertio Therapeutics, Inc (7)
- Astex Pharmaceuticals, Inc (3)
- AUXILIUM PHARMACEUTICALS INC (1)
- AVALON PHARMACEUTICALS INC (3)
- AVENUE THERAPEUTICS, INC. (1)
- AXIM BIOTECHNOLOGIES, INC. (7)
- AYTU BIOSCIENCE, INC (6)
- Bakhu Holdings, Corp. (1)
- Barrel Energy Inc. (2)
- Baudax Bio, Inc. (1)
- Bespoke Extracts, Inc. (2)
- Big Rock Partners Acquisition Corp. (9)
- BIODELIVERY SCIENCES INTERNATIONAL INC (17)
- BioPharmX Corp (6)
- Blue Water Acquisition Corp. (2)
- BODY & MIND INC. (4)
- Bohai Pharmaceuticals Group, Inc. (6)
- Boston Therapeutics, Inc. (13)
- Bristol-Myers Squibb (13)
- Canbiola, Inc. (26)
- Cancer Prevention Pharmaceuticals, Inc. (7)
- Cannabics Pharmaceuticals Inc. (6)
- CANNAPHARMARX, INC. (2)
- CANNAPOWDER, INC. (6)
- Canopy Growth Corp (1)
- CARDAX, INC. (6)
- Celexus, Inc (4)
- CELGENE CORP (20)
- Cerecor Inc. (2)
- Charlotte's Web Holdings, Inc. (1)
- CHINA PHARMA HOLDINGS, INC. (2)
- Cingulate Inc. (10)
- Citius Pharmaceuticals, Inc. (6)
- Clever Leaves Holdings Inc. (3)
- CLS Holdings USA, Inc. (40)
- Cocrystal Pharma, Inc. (9)
- COLLEGIUM PHARMACEUTICAL, INC (2)
- ContraVir Pharmaceuticals, Inc. (2)
- Corcept Therapeutics Incorporated (1)
- CorMedix Inc. (4)
- COSMO VENTURES INC (23)
- CUBIST PHARMACEUTICALS INC (2)
- Cure Pharmaceutical Holding Corp. (12)
- Dova Pharmaceuticals Inc. (1)
- Egalet Corp (1)
- ELITE PHARMACEUTICALS INC (3)
- Eloxx Pharmaceuticals, Inc. (5)
- Endexx Corp (7)
- Endo International plc (1)
- Endo Pharmaceuticals Solutions Inc. (2)
- EPIX Pharmaceuticals, Inc. (3)
- Eton Pharmaceuticals, Inc. (2)
- Evofem Biosciences, Inc. (12)
- Evolus, Inc. (3)
- Exactus, Inc. (10)
- EYENOVIA, INC. (1)
- FERMAVIR PHARMACEUTICALS, INC. (2)
- Furiex Pharmaceuticals, Inc. (1)
- Gala Pharmaceutical Inc. (1)
- GB SCIENCES INC (28)
- GENAISSANCE PHARMACEUTICALS INC (1)
- GREEN HYGIENICS HOLDINGS INC. (5)
- Green Thumb Industries Inc. (2)
- GridIron BioNutrients, Inc. (8)
- GUILFORD PHARMACEUTICALS INC (1)
- HARROW HEALTH, INC. (4)
- Haymaker Acquisition Corp. III (1)
- HERATSI PHARMACEUTICALS (2)
- Horizon Pharma plc (1)
- IMAGING3 INC (19)
- INNOVATE BIOPHARMACEUTICALS, INC. (10)
- Innoviva, Inc. (2)
- IntelGenx Technologies Corp. (6)
- Intersect ENT, Inc. (1)
- ISTA PHARMACEUTICALS INC (1)
- Jaguar Health, Inc. (27)
- Jazz Pharmaceuticals plc (3)
- Jiangbo Pharmaceuticals, Inc. (1)
- Johnson & Johnson (5)
- Journey Medical Corp (1)
- JUNIPER PHARMACEUTICALS INC (3)
- Jushi Holdings Inc. (1)
- Kannalife Inc (5)
- Kaya Holdings, Inc. (5)
- Kedem Pharmaceuticals Inc. (4)
- KEMPHARM, INC (6)
- KID CASTLE EDUCATIONAL CORP (2)
- Level Brands, Inc. (4)
- Lilly (Eli) & Co. (17)
- LIPELLA PHARMACEUTICALS INC (3)
- Lotus Pharmaceuticals, Inc. (1)
- Luckwel Pharmaceuticals Inc. (1)
- Mallinckrodt (9)
- Marijuana Co of America, Inc. (3)
- MedGen, Inc. (6)
- Medicine Man Technologies, Inc. (8)
- MedMen Enterprises, Inc. (3)
- Merck (45)
- MICROCHANNEL TECHNOLOGIES CORP (25)
- Milestone Pharmaceuticals Inc. (1)
- MJ BIOTECH, INC. (3)
- MJ Holdings, Inc. (10)
- Mylan N.V. (3)
- MYnd Analytics, Inc. (59)
- NAREK PHARMACEUTICALS (2)
- NEKTAR THERAPEUTICS (5)
- Neos Therapeutics, Inc. (7)
- Neuralstem, Inc. (1)
- NEW RIVER PHARMACEUTICALS INC (1)
- NewBridge Global Ventures, Inc. (10)
- NEXIEN BIOPHARMA, INC. (4)
- Notis Global, Inc. (23)
- NovaBay Pharmaceuticals, Inc. (10)
- Novan, Inc. (2)
- NPS PHARMACEUTICALS INC (1)
- OCULAR THERAPEUTIX, INC (1)
- OMEROS CORP (10)
- Omthera Pharmaceuticals, Inc. (1)
- One World Pharma, Inc. (14)
- ONYX PHARMACEUTICALS INC (2)
- OPIANT PHARMACEUTICALS, INC. (1)
- OptiNose, Inc. (1)
- OSCIENT PHARMACEUTICALS CORP (2)
- Osmotica Pharmaceuticals plc (3)
- Pacira Pharmaceuticals, Inc. (1)
- Panacea Acquisition Corp (3)
- Paratek Pharmaceuticals, Inc. (1)
- PaxMedica, Inc. (7)
- PEAK PHARMACEUTICALS, INC. (21)
- Perrigo (4)
- PetLife Pharmaceuticals, Inc. (1)
- Petros Pharmaceuticals, Inc. (2)
- Pfizer (3)
- Pharmagreen Biotech Inc. (4)
- Phathom Pharmaceuticals, Inc. (2)
- Phoenix Life Sciences International Limited. (1)
- PLAYERS NETWORK (37)
- PONIARD PHARMACEUTICALS, INC. (2)
- Prestige Brands Holdings Inc (1)
- Processa Pharmaceuticals, Inc. (4)
- ProPhase Labs, Inc. (6)
- PROVECTUS BIOPHARMACEUTICALS, INC. (13)
- QUANTA INC (4)
- RADIENT PHARMACEUTICALS Corp (10)
- Rani Therapeutics Holdings, Inc. (1)
- Recro Pharma, Inc. (3)
- Reliant Pharmaceuticals, Inc. (2)
- RELMADA THERAPEUTICS, INC. (1)
- RespireRx Pharmaceuticals Inc. (23)
- Revance Therapeutics, Inc. (1)
- Rib-X Pharmaceuticals, Inc. (11)
- ROCK CREEK PHARMACEUTICALS, INC. (3)
- SALIX PHARMACEUTICALS LTD (6)
- SCYNEXIS INC (3)
- SenesTech, Inc. (1)
- SHAMAN PHARMACEUTICALS INC (1)
- SIGA TECHNOLOGIES INC (4)
- Sucampo Pharmaceuticals, Inc. (3)
- Sunset Island Group (5)
- Supernus Pharmaceuticals, Inc. (2)
- SYNERGY PHARMACEUTICALS, INC. (2)
- Synovics Pharmaceuticals (2)
- TAPESTRY PHARMACEUTICALS, INC (1)
- Target Group Inc. (5)
- Targeted Medical Pharma, Inc. (1)
- TAURIGA SCIENCES, INC. (76)
- Tenzing Acquisition Corp. (8)
- Terra Tech Corp. (54)
- TETRALOGIC PHARMACEUTICALS CORP (6)
- TETRAPHASE PHARMACEUTICALS INC (1)
- Textmunication Holdings, Inc. (29)
- THAR PHARMACEUTICALS INC (2)
- TherapeuticsMD, Inc. (28)
- Theravance Biopharma, Inc. (2)
- Thomas Pharmaceuticals, Ltd. (2)
- Tilray, Inc. (9)
- TILT Holdings Inc. (13)
- TITAN PHARMACEUTICALS INC (2)
- Tribute Pharmaceuticals Canada Inc. (7)
- Trulieve Cannabis Corp. (2)
- United Cannabis Corp (6)
- Upjohn Inc (1)
- Urigen Pharmaceuticals, Inc. (6)
- Vallon Pharmaceuticals, Inc. (5)
- VASO ACTIVE PHARMACEUTICALS INC (1)
- VERBENA PHARMACEUTICALS INC (2)
- VIA Pharmaceuticals, Inc. (10)
- VION PHARMACEUTICALS INC (1)
- VioQuest Pharmaceuticals, Inc. (3)
- Vireo Health International, Inc. (1)
- Virpax Pharmaceuticals, Inc. (15)
- Vitality Biopharma, Inc. (3)
- VIVUS INC (3)
- WEED, INC. (2)
- XERIS PHARMACEUTICALS INC (1)
- Zoetis (4)
- ZOGENIX, INC. (1)
- Zomedica Pharmaceuticals Corp. (2)
- Note Conversion Agreement, dated September 8, 2023, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Cingulate Inc., Filed With SEC on September 11, 2023)
- Form of Original Issue Discount Secured Convertible Promissory Note (GridIron BioNutrients, Inc., Filed With SEC on September 8, 2023)
- Secured Promissory Note dated August 31, 2023, by the Company in favor of Roger L. Collins, Jr. Schedules and exhibits to this document are omitted pursuant to Item 601(b)(2) of... (Vitality Biopharma, Inc., Filed With SEC on September 5, 2023)
- Secured Promissory Note dated August 31, 2023, by the Company in favor of Roger L. Collins, Jr. Schedules and exhibits to this document are omitted pursuant to Item 601(b)(2) of... (Vitality Biopharma, Inc., Filed With SEC on September 5, 2023)
- CPMD May 25, 2023 Master Note (CANNAPHARMARX, INC., Filed With SEC on September 1, 2023)
- Form of 12% Convertible Promissory Note (IntelGenx Technologies Corp., Filed With SEC on August 31, 2023)
- Amendment No. 1 to Unsecured Promissory Note dated as of August 30, 2023 by and between Acer Therapeutics Inc. and Christopher Schelling (Acer Therapeutics Inc., Filed With SEC on August 31, 2023)
- Note Purchase Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and Nantahala Capital Management, LLC and the other sellers party thereto (KEMPHARM, INC, Filed With SEC on August 31, 2023)
- Promissory Note, dated August 1, 2023 (Textmunication Holdings, Inc., Filed With SEC on August 23, 2023)
- Promissory Note, dated August 9, 2023 (Textmunication Holdings, Inc., Filed With SEC on August 23, 2023)
- Amendment to Forbearance Agreement, dated as of August 15, 2023, among Mallinckrodt International Finance S.A., Mallinckrodt CB LLC and certain holders of the 2028 First Lien Notes (Mallinckrodt, Filed With SEC on August 15, 2023)
- Amendment to Forbearance Agreement, dated as of August 15, 2023, among Mallinckrodt International Finance S.A., Mallinckrodt CB LLC and certain holders of the 2029 Second Lien... (Mallinckrodt, Filed With SEC on August 15, 2023)
- Third Amendment to Note Purchase Agreement, dated August 13, 2023, by and among RevitaLid Pharmaceutical Corp., the Guarantors party thereto, the Purchasers party thereto and... (Osmotica Pharmaceuticals plc, Filed With SEC on August 14, 2023)
- First Amendment to Subordinated Promissory Note (Recro Pharma, Inc., Filed With SEC on August 14, 2023)
- Promissory Note dated April 24, 2023 (MYnd Analytics, Inc., Filed With SEC on August 14, 2023)
- Convertible Promissory Note between Titan Pharmaceuticals, Inc. and Choong Choon Hau (TITAN PHARMACEUTICALS INC, Filed With SEC on August 14, 2023)
- Amendment to Convertible Promissory Note, dated June 30, 2023, by and between NRx Pharmaceuticals, Inc. and Streetervillle Capital LLC (Big Rock Partners Acquisition Corp., Filed With SEC on August 14, 2023)
- Form of Senior Subordinated Convertible Note (Evofem Biosciences, Inc., Filed With SEC on August 10, 2023)
- Form of Convertible Note dated April 28, 2023 (Vireo Health International, Inc., Filed With SEC on August 4, 2023)
- Unsecured Promissory Note between Titan Pharmaceuticals, Inc. and David E. Lazar (TITAN PHARMACEUTICALS INC, Filed With SEC on July 28, 2023)
- Second Amendment to Convertible Promissory Note, dated July 7, 2023, by and between NRx Pharmaceuticals, Inc. and Streetervillle Capital LLC (Big Rock Partners Acquisition Corp., Filed With SEC on July 28, 2023)
- Forbearance Agreement, dated as of July 16, 2023, among Mallinckrodt International Finance S.A., Mallinckrodt CB LLC and certain holders of the 2029 Second Lien Notes (Mallinckrodt, Filed With SEC on July 17, 2023)
- Forbearance Agreement, dated as of July 16, 2023, among Mallinckrodt International Finance S.A., Mallinckrodt CB LLC and certain holders of the 2028 First Lien Notes (Mallinckrodt, Filed With SEC on July 17, 2023)
- Form of Senior Subordinated Convertible Note (Evofem Biosciences, Inc., Filed With SEC on July 10, 2023)
- Promissory Note of the Company in the Principal Amount of $300,000 issued to AJB Capital Investments LLC, dated June 23, 2023 (One World Pharma, Inc., Filed With SEC on July 5, 2023)
- Amended, Consolidated and Restated Secured Promissory Note dated November 10, 2022 issued to John Schutte (ACURA PHARMACEUTICALS, INC, Filed With SEC on June 30, 2023)
- Unsecured Promissory Note, dated as of June 22, 2023, between Acer Therapeutics Inc. and Christopher Schelling (Acer Therapeutics Inc., Filed With SEC on June 26, 2023)
- 15% OID Senior Promissory Note, dated June 20, 2023 (Textmunication Holdings, Inc., Filed With SEC on June 23, 2023)
- Promissory Note, dated June 1, 2023, by and between Evergreen Holdco, LLC and Sucellus, LLC (Medicine Man Technologies, Inc., Filed With SEC on June 7, 2023)
- CONVERTIBLE NOTE (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on May 30, 2023)
- RespireRx-Marc M. Radin PC Demand Promissory Note dated May 22, 2023 (RespireRx Pharmaceuticals Inc., Filed With SEC on May 24, 2023)
- RespireRx-Arnold Lippa Family Trust of 2007 Demand Promissory Note dated May 22, 2023 (RespireRx Pharmaceuticals Inc., Filed With SEC on May 24, 2023)
- Walleye May 2023 Promissory Note (Canbiola, Inc., Filed With SEC on May 22, 2023)
- Promissory Note dated as of May 8, 2023, issued by the Registrant to Bixi Gao & Ling Ling Wang (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on May 19, 2023)
- Promissory Note dated as of May 8, 2023, issued by the Registrant to Steel Anderson (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on May 19, 2023)
- Promissory Note dated as of May 8, 2023, issued by the Registrant to Ariana Bakery Inc (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on May 19, 2023)
- Promissory Note dated as of May 8, 2023, issued by the Registrant to Cyberbahn Federal Solutions, LLC (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on May 19, 2023)
- Amendment No. 3 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, dated May 19, 2023 (APRICUS BIOSCIENCES, INC., Filed With SEC on May 19, 2023)
- Form of 2023 Bridge Notes (TILT Holdings Inc., Filed With SEC on May 19, 2023)
- Secured Note Purchase Agreement dated May 15, 2023 by and among TILT Holdings Inc., Jimmy Jang, L.P., Baker Technologies, Inc., Commonwealth Alternative Care, Inc., Jupiter... (TILT Holdings Inc., Filed With SEC on May 19, 2023)